<?xml version="1.0" encoding="UTF-8"?>
<p id="par0110">In our trial, twenty-six Covid-19 patients had no severe adverse reactions after CP transfusion. Accordingly to the literature, statistically significant difference was found between age and lymphocyte values of living and dying patients. The patients who died were determined to have older age and more severe lymphopenia.</p>
